NCT07402473
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07402473
Title EUREKA Study:Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
RWJBarnabas Health - Trinitas Hospital and Comprehensive Cancer Center Elizabeth New Jersey 07202 United States Details
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton Hamilton New Jersey 08690 United States Details
RWJBarnabas Health - Monmouth Medical Center Long Branch New Jersey 07740 United States Details
Rutgers Cancer Institute New Brunswick New Jersey 08901 United States Details
RWJBarnabas Health - Newark Beth Israel Medical Center Newark New Jersey 07112 United States Details
RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset Somerville New Jersey 08876 United States Details
RWJBarnabas Health - Community Medical Center Toms River New Jersey 08755 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field